1. 96PPreliminary pharmacokinetic results from a phase I study of GBR 1302 in patients with HER2 positive cancers. (17th December 2018) Authors: Gudi, G; Ca, V; Gn, S; von Gunten, C; Fluhler, E; Back, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗